Alkermes Plc (NASDAQ:ALKS)

45.58
Delayed Data
As of May 22
 +0.36 / +0.80%
Today’s Change
41.15
Today|||52-Week Range
71.22
-16.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.3B

Company Description

Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U.S., Ireland, Rest of the World, and Other. Its products include the brands Aristada and Vivitrol. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin D04 C5Y6
P:(531) 772-8000
Investor Relations:
(781) 609-6377

Employees

Shareholders

Mutual fund holders75.31%
Other institutional28.67%
Individual stakeholders1.15%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
James RobinsonPresident & Chief Operating Officer
Jim FratesChief Financial Officer & Senior Vice President
Craig C. HopkinsonChief Medical Officer & SVP-Medicine Development
David Jose GaffinSecretary, Chief Legal & Compliance Officer, SVP